iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
May 10, 2024 08:26 ET
|
iTeos Therapeutics Inc.
- Belrestotug + dostarlimab exceeded pre-defined efficacy criteria for clinically relevant activity observed in an interim assessment of Phase 2 GALAXIES Lung-201- Clinically meaningful tumor...
iTeos Therapeutics Announces $120 Million Registered Direct Offering
May 10, 2024 08:24 ET
|
iTeos Therapeutics Inc.
- Led by existing investors RA Capital Management and Boxer Capital- Purchase price of $17.50 represents a premium of approximately 44% to last close- Further strengthens balance sheet with pro forma...
Solutran Awarded WIC EBT Contracts for Indian Tribal Organizations
January 31, 2022 15:38 ET
|
Solutran
MINNEAPOLIS, MN, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Solutran announced that it received awards to provide online and smart card WIC EBT solutions for Indian Tribal Organizations located in Maine and...